STREAM clinical trial results provide vital insight into nine-month treatment regimen for multidrug-resistant tuberculosis (PDF 87 KB)
Preliminary results from Stage 1 of the STREAM randomised clinical trial show that the nine-month treatment regimen being tested achieved favourable outcomes in almost 80 percent of those treated.
Wirelessly Observed Therapy could revolutionise tuberculosis treatment, researchers to tell the 48th Union World Conference on Lung Health in Guadalajara, Mexico, 11-14 October, 2017 (PDF 60 KB)
A range of new technological advances in the diagnosis and treatment of tuberculosis to be unveiled for the first time in Guadalajara.
The Union welcomes the WHO's recognition of TB alongside other pathogens as priority for R&D
The Union welcomes the WHO’s Priority Pathogen Report, released today, highlighting drug-resistant tuberculosis (DR-TB) as a priority for research and development in the battle against AMR.
Breakthrough research linking diabetes and TB infection to be announced at the 48th Union World Conference on Lung Health in Guadalajara (PDF 153 KB)
Conference to be opened by the Mexican Secretary of Health, Dr José Narro Robles and feature address by H.E. Dr Tabaré Ramón Vázquez Rosas, President of Uruguay
The Union welcomes major finance firms’ pledge of public support for tobacco control
On World No Tobacco Day, The Union welcomes the announcement from 53 leading finance firms that today affirmed their public support for international efforts to reduce tobacco use under the WHO FCTC.
Forum of International Respiratory Societies (FIRS) issues five key points, critical to addressing tuberculosis epidemic (PDF 125 KB)
In support of World TB Day, 24 March, the Forum of International Respiratory Societies (FIRS) urges action on five united strategies to ensure the aim of ending tuberculosis (TB) by 2030 becomes achievable, despite new and emerging challenges.